Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Jun 4;21(1):129.
doi: 10.1186/s13054-017-1709-y.

Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report

Serge Jennes  1 , Maia Merabishvili  2 , Patrick Soentjens  3 , Kim Win Pang  3 , Thomas Rose  1 , Elkana Keersebilck  1 , Olivier Soete  1 , Pierre-Michel François  1 , Simona Teodorescu  1 , Gunther Verween  2 , Gilbert Verbeken  2 , Daniel De Vos  2 , Jean-Paul Pirnay  4
Affiliations
Case Reports

Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report

Serge Jennes et al. Crit Care. .
No abstract available

Keywords: Acute kidney injury; Antibiotic resistance; Bacteraemia; Bacteriophage therapy; Colistin; Intravenous; Pseudomonas aeruginosa.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Large pressure sores in the sacral and spinal back areas. Situation on 17 November 2016
Fig. 2
Fig. 2
Timeline showing relevant clinical parameters and treatments. Dotted lines mark the upper threshold values. CRP C-reactive protein
See this image and copyright information in PMC

References

    1. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2013;310:2191–4. doi: 10.1001/jama.2013.281053. - DOI - PubMed
    1. Merabishvili M, Pirnay JP, Verbeken G, Chanishvili N, Tediashvili M, Lashkhi N, et al. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS One. 2009;4:e4944. doi: 10.1371/journal.pone.0004944. - DOI - PMC - PubMed
    1. Speck P, Smithyman A. Safety and efficacy of phage therapy via the intravenous route. FEMS Microbiol Lett. 2016;363:fnv242. doi: 10.1093/femsle/fnv242. - DOI - PubMed